Appili Therapeutics Inc. (TSX:APLI)

Appili Therapeutics Balance Sheet

Financials in millions CAD. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	0.21	1.23	0.09	2.47	6.66	11.06
Short-Term Investments	-	-	-	-	-	5.06
Cash & Short-Term Investments	0.21	1.23	0.09	2.47	6.66	16.12
Cash Growth	14.28%	1199.82%	-96.17%	-63.00%	-58.67%	52.98%
Accounts Receivable	0.17	1.66	1.16	0.12	0.47	1.03
Other Receivables	0.01	0.01	0.02	0.3	0.92	0.65
Total Trade Receivables	0.18	1.67	1.17	0.42	1.39	1.69
Other Current Assets	0.14	0.11	0.19	0.23	0.18	0.45
Total Current Assets	0.54	3.01	1.46	3.12	8.24	18.26
Net Property, Plant & Equipment	0.01	0.02	0.03	0.01	0.04	0.05
Total Assets	0.55	3.03	1.49	3.13	8.28	18.32
Accounts Payable	4.45	4.11	4.18	2.82	6.46	4.53
Current Portion of Long-Term Debt	11.72	11.56	7.31	0.11	0.1	0.09
Unearned Revenue	-	-	-	-	0.12	-
Other Current Liabilities	0.03	0.03	0.05	0.04	-	-
Total Current Liabilities	16.2	15.69	11.54	2.98	6.67	4.62
Long-Term Debt	0.74	0.74	0.88	7.55	4.88	0.95
Total Long-Term Liabilities	0.74	0.74	0.88	7.55	4.88	0.95
Total Liabilities	16.93	16.43	12.42	10.53	11.55	5.56
Shareholders' Equity	-16.38	-13.4	-10.92	-7.4	-3.27	12.75
Total Liabilities & Equity	0.55	3.03	1.49	3.13	8.28	18.32
Total Debt	12.46	12.29	8.18	7.67	4.98	1.03
Net Cash (Debt)	-12.25	-11.07	-8.09	-5.2	1.69	15.09
Net Cash Growth	-	-	-	-	-88.83%	58.28%
Net Cash Per Share	-0.10	-0.09	-0.07	-0.05	0.03	0.26

Updated Feb 12, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.